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Abstract
Background: While the effects of daily fine particulate exposure (PM) have been well reviewed, the epidemiological 
and physiological evidence of cardiovascular effects associated to sub-daily exposures has not. We performed a 
theoretical model-driven systematic non-meta-analytical literature review to document the association between PM 
sub-daily exposures (≤6 hours) and arrhythmia, ischemia and myocardial infarction (MI) as well as the likely 
mechanisms by which sub-daily PM exposures might induce these acute cardiovascular effects. This review was 
motivated by the assessment of the risk of exposure to elevated sub-daily levels of PM during fireworks displays.
Methods: Medline and Elsevier's EMBase were consulted for the years 1996-2008. Search keywords covered potential 
cardiovascular effects, the pollutant of interest and the short duration of the exposure. Only epidemiological and 
experimental studies of adult humans (age > 18 yrs) published in English were reviewed. Information on design, 
population and PM exposure characteristics, and presence of an association with selected cardiovascular effects or 
physiological assessments was extracted from retrieved articles.
Results: Of 231 articles identified, 49 were reviewed. Of these, 17 addressed the relationship between sub-daily 
exposures to PM and cardiovascular effects: five assessed ST-segment depression indicating ischemia, eight assessed 
arrhythmia or fibrillation and five considered MI. Epidemiologic studies suggest that exposure to sub-daily levels of PM 
is associated with MI and ischemic events in the elderly. Epidemiological studies of sub-daily exposures suggest a 
plausible biological mechanism involving the autonomic nervous system while experimental studies suggest that 
vasomotor dysfunction may also relate to the occurrence of MI and ischemic events.
Conclusions: Future studies should clarify associations between cardiovascular effects of sub-daily PM exposure with 
PM size fraction and concurrent gaseous pollutant exposures. Experimental studies appear more promising for 
elucidating the physiological mechanisms, time courses and causes than epidemiological studies which employ 
central pollution monitors for measuring effects and for assessing their time course. Although further studies are 
needed to strengthen the evidence, given that exposure to sub-daily high levels of PM (for a few hours) is frequent and 
given the suggestive evidence that sub-daily PM exposures are associated with the occurrence of cardiovascular 
effects, we recommend that persons with cardiovascular diseases avoid such situations.
Background
Exposure to higher than usual levels of ambient particu-
late air pollution over the course of several hours to sev-
e r a l  d a y s  h a s  b e e n  s h o w n  t o  c o n t r i b u t e  t o  a c u t e
cardiovascular events such as arrhythmia, ischemia and
myocardial infarction, which all could lead to emergency
department visits, hospitalisation and death [1-3].
Various physiological pathways have been proposed to
explain such cardiovascular effects. As presented in fig-
ure 1, likely mechanisms by which sub-daily levels of fine
particles (PM) induce acute cardiovascular effects may
involve the autonomic nervous system, systemic inflam-
mation, vasomotor dysfunction and/or thrombogenesis
[1-3].
While acute effects appear to occur soon after exposure
to ambient PM [2], only recently have studies addressed
whether cardiovascular events and exacerbations of
respiratory disease symptoms associated with exposure
to ambient PM relate mainly to brief (minutes or hourly)
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h i g h - l e v e l  e x p o s u r e  o f  p a r t i c l e s  o r  i f  t h e y  r e s u l t  f r o m
exposure averaged over an entire day. As such, sub-daily
levels of PM are not regulated as is the case with other air
pollutants for which sub-daily standards have been set
(e.g. 1 h standard for ozone). Furthermore, guidance for
vulnerable persons faced with high sub-daily exposure
situations is lacking even if such exposures occur in many
real-life situations such as in traffic jams, at bus stops,
during accidental fires and explosions, in arenas, in
indoor parking garages, during fireworks displays, etc.
Much of our understanding of the epidemiology of
short-term ambient PM exposure derives from the link-
age of administrative records of population health data
with air pollution levels obtained from fixed site ambient
monitors. Given that the precise timing of death, hospital
admissions, and emergency room visits, are rarely avail-
able in administrative databases, epidemiological assess-
ments based on such databases have not adequately
addressed the effects of sub-daily high-level ambient par-
ticulate exposures.
We conducted a theoretical model-driven non-meta-
analytic systematic literature review of published studies
performed in humans, with the objective of providing a
comprehensive evaluation of the cardiovascular effects of
sub-daily exposures (≤6 hours) to ambient PM. A model-
driven synthesis is a review that incorporates a concep-
tual model (see figure 1) and that attempts to provide
information about the set of relationships among con-
s t r u c t s  o f  v a r i a b l e s  [ 4 ] .  W e  c h o s e  t h i s  a p p r o a c h  i n  a n
attempt to delineate information gaps meriting further
research with regards to the likely mechanisms whereby
sub-daily exposures to PM may induce acute cardiovas-
cular effects. The model was used to define the keywords
and, to organise and analyse the existing research.
The main questions addressed by this review are: 1)
Does short duration exposure (sub-daily) to PM induce
cardiovascular effects such as arrhythmia, ischemia and
infarction?; 2) Do cardiovascular effects following short
duration exposure to PM occur quickly after exposure?;
3) What are the likely mechanisms whereby sub-daily
exposures to PM may induce acute cardiovascular effects
such as arrhythmia, ischemia and infarction?
Methods
Data Sources
The bibliographic databases consulted were Medline and
Elsevier's EMBase, using the Ovid portal. The temporal
limits used were January 1996 to December 2008. Our
search started in 1996 as no information was yet pub-
lished on the subject before 1996, according to the 2004
U.S. Environmental Protection Agency Air quality crite-
ria document for particulate matter [2].
Data Extraction
The search strategy consisted of a combination of
descriptors representing 1) cardiovascular effects (e.g.
myocardial infarction), 2) the pollutant of interest (e.g.
ambient PM) and, 3) the short duration of the exposure
(e.g. short-term, peaks). The limits defined the age
groups in which the study was performed (adults, age ≥
18 years) and the language in which the study was pub-
lished (English).
Only peer-reviewed scientific articles were retrieved.
They were then selected by hand according to the follow-
ing exclusion criteria: occupational studies; studies where
exposure was to tobacco smoke, studies performed in
animals, studies where there was no exposure to PM or
studies where neither myocardial infarction (MI),
arrhythmia, ischemia, nor vasomotor tone, thrombogen-
esis or heart rate and rhythm were measured. Commen-
taries, opinion and review articles were not analysed and
neither were studies where exposure was for durations
greater than 6 hours. Furthermore, only one publication
of the same study/database was considered. The refer-
ences cited in the selected articles were then searched to
ensure completeness of the information gathered.
Data Synthesis Method
Selected studies were organised into groups addressing
specific sets of relationships among the construct of vari-
ables, presented in Figure 1. This figure was based on two
important reviews by Brook et al. [1] and Mills et al. [3].
The following information was extracted from each arti-
cle: design (human experimental or epidemiological stud-
ies), population characteristics (age and the presence of
pre-existing cardiovascular disease; the latter were
assumed to be on medication), particulate exposure char-
acteristics (mass and number concentrations of particles
with median diameters smaller than 10 μm, elemental
and organic carbon levels and, duration and lags used) as
well as presence of an association with the following
health effects or physiological assessments: ST-segment
depression, cardiac arrhythmia, MI, vasoconstriction
assessed with blood pressure measurement, brachial
Figure 1 Likely mechanisms whereby sub-daily exposures of fine 
particles (PM) induce acute cardiovascular effects (arrhythmia, 
ischemia and infarction). Adapted from Brook et al. [1] and Mills et al 
[3].
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artery diameter (BAD), flow mediated dilation (FMD) or
forearm blood flow (FBF), changes in the standard devia-
tion of all the normal-to-normal intervals (SDNN) on
electrocardiogram and increased coagulation assessed
with fibrinogen, platelet or tissue-plasminogen activator
(t-PA) antigen levels. ST-segment depression (as a proxy
for ischemia), arrhythmia and MI were considered as
health effects; the other physiological assessments were
analysed as measurements made to clarify mechanisms
whereby sub-daily exposures to PM induce acute cardio-
vascular effects.
In the selected articles assessing the association
between exposure to sub-daily levels of PM and heart rate
variability measures, both time and frequency domains
have been assessed but for simplification, here we only
report on SDNN. Furthermore, blood markers of coagu-
lation other than fibrinogen, platelets and t-PA were iden-
tified in the literature but as they were not consistently
measured in many studies, they were not considered in
our analysis. Moreover, associations with pollutants other
than to particulate matter are not reported in the present
study. When studies reported on the effects of both sub-
d a i l y  a n d  d a i l y  e x p o s u r e  t o  P M ,  w e  o n l y  r e p o r t e d  t h e
effects of sub-daily exposure as we did not review all
studies where exposure to PM was longer than 6 hours in
duration (including 24 hour studies) and only in a minor-
ity of studies that we reviewed were both hourly and daily
exposure durations reported.
For our assessment of the literature, we defined a lag as
the difference in hours between the end of the exposure
and a physiological assessment or a health effect. For
example, if MI occurred at 17 h00 and an exposure to PM
at 14 h00 to 16 h00 is being considered, then the lag is 1 h
and the duration of exposure is 2 h. In some instances,
particularly in experimental studies, lag0 also included
assessments made during the exposure. We report results
for all lags assessed but again only results where exposure
duration was 6 hours or less. We identified the presence
of an association based on statistical significance. We did
not perform a meta-analysis of available studies. A meta-
analytic review that examines the magnitude of effects at
different lags, for different outcome and PM size, is
beyond the scope of this article. The objective of our
comprehensive review was to assess whether acute effects
of sub-daily PM exposures have been reported. The
method used to quantitatively assess the evidence for
each set of relationships was limited to vote-counting of
statistically significant associations [5]. An association
was considered 'suggestive' if more than half of the stud-
ies measuring the same effect showed an association in
the same direction. If there were associations in fewer
than half of the studies or, if the results were contradic-
tory, we considered that there was limited evidence.
Results
Description of studies
Figure 2 presents a flow chart of the stages of the selec-
tion of the studies for analysis. The initial key word
search yielded 235 articles but four articles were excluded
to retain only one article per study. Applying the above
mentioned inclusion/exclusion criteria left 47 articles. To
these 47 articles in which the duration of exposure was
under or equal to 6 hours, five more articles were
obtained from reference snowballing, for a total of 52
articles reviewed.
The information retrieved from 49 of the 52 studies is
organised into four tables (Table 1, Table 2, Table 3 and
Table 4) addressing the following sets of relationships
with sub-daily exposures to PM that can be derived from
Figure 1: i) cardiovascular effects (n = 17): five studies
assessed ST-segment depression [6-10] which most likely
indicated ischemia, eight studies arrhythmia or fibrilla-
tion [9,11-17] and, five studies were on MI [18-22]; ii)
heart rate variability (SDNN): n = 20 [15-17,23-39]; iii)
vasoconstriction: n = 17 [9,10,15-17,36,38,40-49]; iv)
coagulation: n = 15 [9,10,15,17,36,38,39,43,44,48,50-54].
The remaining three studies [55-57] were excluded as
they did not report on the presence of an association with
the health effects or physiological assessments presented
in Table 1, Table 2, Table 3 and Table 4 which were
Figure 2 Progress through the stages of the selection of studies 
for analysis.
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Table 1: Evidence of association between sub-daily exposure to PM and arrhythmia, ischemia and myocardial infarctiona
Authors Subjects Design Exposure Levels Dur. Lags Effect
ST-Segment depression
Chuang et al., 2008 Aged 43-75 yrs, with 
CVD
Epi. Fixed site PM2.5 mean daily levels: 
50th: 9 μg/m3, (max 40); BC 
measured;
1 to 6 hb Lag0 -
Gold et al., 2005 Aged 61-88 yrs Epi. Fixed site PM2.5, 12 h mean levels: 
10th: 4, 90th: 26 μg/m3; BC also 
measured;
1 hb Lag1 to 12 h ￿ at lag1 to 12 with BC
Lanki et al., 2008 Mean age 68 yrs 
(SD7), with CVD
Epi. Assessment 
during exercise
Fixed site PM2.5 hrly levels: 25th: 9, 
75th: 18 μg/m3; fixed site UFP also 
measured; personal measurements 
made;
1 and 4 hb Lag0 to 24 h; ￿ at lag1 to 10 with 
PM2.5 1 h; ￿ with 4 h 
dur. pre-testing
Gong et al., 2003 Aged 18-45 yrs, 50% 
asthmatics
Exp. CAP~PM2.5 : 174 μg/m3 (SD37) with 
exercise;
2 h Lag0_4c 4_22 h -
Mills et al., 2007b Mean age 60 yrs 
(SD1), with prior MI
Exp. Diesel PM : 300 μg/m3 with exercise; 1 h Lag0 ￿ at lag0
Fibrillation -arrhythmia
Ljungman et al., 2008 Mean age 62 yrs 
(SD13), with ICD
Epi. Fixed site PM10 mean 2 h levels: 2 
cities 50th: 19-15 μg/m3; PM2.5 
measured in one city;
2 hb Lag0 ￿ v. arrhythmia with 
PM10; - with PM2.5
Rich et al., 2006 Aged 45-78 yrs, with 
ICD
Epi. Fixed site PM2.5 hrly 50th: 9 μg/m3 
(25th: 6, 75th: 15); BC also measured;
1 hb Lag0 - a. fibrillation
Rich et al., 2006b Mean age 63 yrs (20-
88), with ICD
Epi. Fixed site PM2.5 hrly 50th: 16 μg/m3 
(25th: 12, 75th: 22); BC and OC also 
measured;
6 h Lag0 - v. arrhythmiaB
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Rich et al., 2005 Mean age 64 yrs (19-
90), with ICD
Epi. Fixed site PM2.5 hrly 50th: 9 μg/m3 
(25th: 16, 75th: 15); BC also measured;
2 and 6 hb Lag0 - v. arrhythmia
Gong et al., 2008 Aged 18-50 yrs, 45% 
asthmatics
Exp. CAP~UFP : 100 μg/m3 (SD68) with 
exercise;
2 h Lag0_4c 4_22 h - ectopic beats
Gong et al., 2004 Mean age 36 yrs 
(SD11), 75% 
asthmatics
Exp. CAP~PM10 : 157 μg/m3 (SD41) with 
exercise;
2 h Lag0_4c 4_22 h - ectopic beats
Gong et al., 2004b Aged 54-85 yrs, 68% 
COPD
Exp. CAP~PM2.5 : 167 (SD27) μg/m3; 
with exercise;
2 h Lag0_4c 4_22 h - ectopic beatsd
Gong et al., 2003 Aged 18-45 yrs, 50% 
asthmatics
Exp. CAP~PM2.5 : 174 μg/m3 (SD37) with 
exercise;
2 h Lag0_4c 4_22 h - ectopic beats
Myocardial Infarction and cardiac arrest
Murakami et al., 2006 Deaths for MI, mean 
age 72 yrs (SD13)
Epi. Fixed site PM7 hrly 50th: 44 μg/m3 
(0-1093);
1 to 6hb Lag0 ￿
Peters et al., 2005 MI subjects, mean 
age 60 yrs (25-74)
Epi. Fixed site PM2.5 hrly 50th: 15 μg/m3 
(25th: 11, 75th: 20); UFP also 
measured; Exposure to traffic;
1 hb Lag0 to 6 h and 24 h - with PM2.5 or UFP; ￿ 
with traffic at lag0 to 
6 h
Peters et al., 2001 MI subjects, mean 
age 62 yrs (SD13)
Epi. Fixed site PM2.5 hrly mean: 12 μg/
m3 (SD9);
1 hb Lag0 to 5 h and 24 h ￿ at lag0 to 2 h
Rosenthal et al., 2008 Cardiac arrest 
subjects, mean age 
61 yrs (SD17)
Epi. Fixed site PM2.5 hrly 50th: 14 μg/m3 
(10th: 6, 90th: 30);
1 and 4 hb Lag0 to 8 h ￿ at lag0 and 1 h
Sullivan et al., 2005 MI subjects, mean 
age 69 yrs (21-98)
Epi. Fixed site PM2.5 hrly 50th: 8.6 μg/m3 
(2-147);
1, 2, 4 hb Lag0 -
a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Lag0_4 includes up to 90 minutes before the beginning of exposure; d 
Inconsistent results were reported between population subgroups (e.g. normal and asthmatics);
Abbreviations: a. fibrillation: Atrial fibrillation; BC: Black carbon; CAP: Concentrated ambient particles; CVD: Cardiovascular disease; COPD: Chronic obstructive pulmonary disease; Dur.: Duration 
of exposure; Epi.: Epidemiological; Exp.: Experimental; hrly: Hourly; ICD: Implantable cardioverter defibrillators; MI: Myocardial infarction; OC organic carbon; PM: Fine particles; SD: Standard 
deviation; UFP: Ultrafine particles; v. arrhythmia: Ventricular arrhythmia; -: No significant statistical association;
Table 1: Evidence of association between sub-daily exposure to PM and arrhythmia, ischemia and myocardial infarctiona (Continued)B
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Table 2: Evidence of association between sub-daily exposure to PM and SDNNa
Authors Subjects Design Exposure Levels Dur. Lags SDNN
Adar et al., 2007 Aged 62-92 yrs, 82% HT Epi. PM2.5 mean on bus: 17 μg/
m3 (SD10); BC also measured;
5', 30', 1, 4 hb Lag0 ￿ with PM2.5 and BC 
(more on bus (5' dur.)
Chang et al., 2007 Mean age 66 yrs (SD7), 47% 
CVD, 60% HT
Epi. Mean personal PM2.5: 31 μg/
m3 (SD27); Other PM size also 
measured;
1 to 6 hb Lag0 ￿ with PM2.5-10; ￿ 
with PM1-2.5
Chuang et al., 2007 Mean age 70 yrs (SD12), with or 
at risk of CVD
Epi. Fixed site PM2.5 hrly mean: 
52 μg/m3 (SD40); SO42- and 
OC also measured;
1 to 4 h Lag0 ￿ mostly with SO42-
Chuang et al. 2005 Mean age 68.1 yrs (SD3.6), 39% 
CVD, 61% HT
Epi. Mean personal PM1-2.5: 
CVD:11 μg/m3 (SD9) and HT 
13 (SD8);
1 to 4 h Lag0 ￿ with PM0.3-1; - with 
PM1-10
Gold et al., 2000 Mean age 73 yrs (53-87), 29% 
CVD, 57% HT
Epi. Fixed site PM2.5, 4 h mean: 15 
μg/m3 (3-49); PM10 also 
measured;
1 and 4 hb Lag0 ￿ with PM2.5
Lipsett et al., 2006 Mean age 71 yrs (SD6), with 
CVD
Epi. Fixed site PM2.5 daily mean at 
2 sites: 23 μg/m3 (6-90) and 
14 (5-52); PM10 also 
measured;
2, 4, 6 hb Lag0 ￿ with PM10; - with 
PM2.5
Magari et al., 2002 Mean age 43 yrs (SD13) Epi. Daily mean personal PM2.5: 
150 μg/m3 (SD292);
15'to 6 hb Lag0 ￿ up to 6 h dur.
Luttmann-Gibson et al., 2006 Mean age 71 yrs (54-90), 84% 
CVD
Epi. Fixed site PM2.5 daily mean: 
20 μg/m3 (25th: 12, 75th: 25); 
SO42- and elemental carbon 
(EC) also measured;
4 and 6 hb Lag0 -
Sullivan et al., 2005b Median age 77 yrs (57-87), 62% 
CVD
Epi. Hrly mean outside home 
PM2.5: 11 μg/m3 (3-40);
1 and 4 hb Lag0 -B
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Vallejo et al., 2006 Mean age 27 yrs (21-35) Epi. Median personal PM2.5: 74 
μg/m3 (25th: 49, 75th: 111);
30' to 210' Lag0 -
Wheeler et al., 2006 Aged 49-76 yrs, 46% CVD, 54% 
COPD
Epi. Fixed site PM2.5, 4 h mean:: 
18 μg/m3 (25th: 12, 75th: 22);
1 and 4 hb Lag0 -
Beckett et al., 2005 Mean age 35 yrs (23-52) Exp. UFP and fine Zn PM: 500 μg/
m3;
2 h Lag0, 3, 6, 11, 23 h -
Devlin et al., 2003 Mean age 67 yrs (SD1) Exp. CAP < PM2.5: 41 μg/m3 (SD9); 
with exercise;
2 h Lag0 and 24 h -
Frampton et al., 2004 Aged 18-40 yrs, 57% asthmatics Exp. UFP: 10 or 25 μg/m3; with 
exercise;
2 h Lag0, 3.5, 15, 21, 45 h -
Gong et al., 2008 Aged 18-50 yrs, 45% asthmatics Exp. CAP~UFP: 100 μg/m3 (SD68) 
for 2 h with exercise;
2 h Lag0, 4, 22 h -
Gong et al., 2004 Mean age 36 yrs (SD11), 75% 
asthmatics
Exp. CAP~PM10 : 157 μg/m3 
(SD41) with exercise;
2 h Lag0, 4, 22 hc -
Gong et al., 2004b Aged 54-85 yrs, 68% COPD Exp. CAP~PM2.5 : 167 (SD27) μg/
m3; with exercise;
2 h Lag0, 4, 22 h -
Peretz et al., 2008 Aged 24-48 yrs Exp. Diesel PM: 100 and 200 μg/
m3 for 2 h;
2 h Lag0, 1, 4, 20 h -
Routledge et al., 2006 Aged 52-75 yrs, 50% CVD Exp. C UFP: 50 μg/m3; 1 h Lag0 and 4 h ￿
Scharrer et al., 2007 Mean age 29 yrs (SD8) Exp. Welding fume PM 50th: 3500 
μg/m3 (1000-25300);
1 h Lag 5 h -
a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied;
Abbreviations: BC: Black carbon; C: Carbon; CAP: Concentrated ambient particles; COPD: Chronic obstructive pulmonary disease; CVD: Cardiovascular disease; Dur.: Duration of exposure; Epi.: 
Epidemiological; Exp.: Experimental; hrly: Hourly; HT: Hypertensive; OC Organic carbon; PM: Fine particles; SD: Standard deviation; SDNN: Standard deviation of all the normal-to-normal intervals; 
UFP: Ultrafine particles -: No significant statistical association;
Table 2: Evidence of association between sub-daily exposure to PM and SDNNa (Continued)B
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Table 3: Evidence of association between sub-daily exposure to PM and vasoconstrictiona
Authors Subjects Design Exposure Levels Dur. Lags Vasocon- striction
Harrabi et al., 2006 Mean age 75 yrs (SD5), 
46% HT, 6% MI
Epi. Fixed site PM10 hrly mean: 20 μg/m3 (SD10); 
SO42- and OC also measured;
1 hb Lag0, 3, 5, 24 h ￿SBP at lag3 and 5 h
Brook et al., 2002 Mean age 35 yrs (SD10) Exp. CAP~PM2.5: 153 μg/m3 (SD35) + O3; 2-2.5 h Lag0 ￿BAD; -BP and FMD
Dales et al., 2007 Aged 18-50 yrs Exp. PM2.5 bus stop 1: 40 μg/m3 (SD20); PM2.5 bus 
stop 2: 10 μg/m3 (SD10); PM1 also measured;
2 h Lag0 ￿FMD with PM2.5 not 
with PM1; -BP
Frampton et al., 2004 Aged 18-40 yrs, 57% 
asthmatics
Exp. UFP: 10 or 25 μg/m3; with exercise; 2 h Lag0, 3.5, 15, 21, 45 h -BP
Gong et al., 2008 Aged 18-50 yrs, 45% 
asthmatics
Exp. CAP~UFP: 100 μg/m3 (SD68) with exercise; 2 h Lag0, 4, 22 h -BP
Gong et al., 2004b Aged 54-85 yrs, 68% COPD Exp. CAP~PM2.5 : 167 (SD27) μg/m3; with exercise; 2 h Lag0, 4, 22 h -BP
Gong et al., 2004 Mean age 36 yrs (SD11), 
75% asthmatics
Exp. CAP~PM10 : 157 μg/m3 (SD41) with exercise; 2 h Lag0, 4, 22 h -BP
Gong et al., 2003 Aged 18-45 yrs, 50% 
asthmatics
Exp. CAP~PM2.5 : 174 μg/m3 (SD37) with exercise; 2 h Lag0, 4, 22 h -BPc
Mills et al., 2008 Mean age 54 yrs (SD2), 
50% CVD
Exp. CAP~PM2.5 : 190 μg/m3 (SD37); with exercise; 2 h Lag6 to 8 h -FBF with vasodil. or 
not; -BP
Mills et al., 2007b Mean age 60 yrs (SD1), 
with prior MI
Exp. Diesel PM : 300 μg/m3; with exercise; 1 h Lag6 to 8 h -FBF with vasodil. or 
not; -BP
Mills et al., 2005 Aged 20-38 yrs Exp. Diesel PM : 300 μg/m3; with exercise; 2 h Lag2, 6, 24 h ￿FBF with vasodil.; -BP
Peretz et al., 2008b Aged 20-48 yrs Exp. Diesel PM: 100 and 200 μg/m3; 2 h Lag0 and 3 h ￿BAD; -FMD and BP
Routledge et al., 2006 Aged 52-75 yrs, 50% CVD Exp. C UFP: 50 μg/m3; 1 h Lag0 and 4 h -BPB
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Rundell et al., 2007 Mean age 21 yrs (SD2) Exp. Nb of PM1 near busy road: 144K/cm3 (SD59K); 
with exercise;
for 30' Lag0 ￿BAD and FMD
Shah et al., 2008 Aged 18-40 yrs Exp. C UFP: 50 μg/m3; with exercise; 2 h Lag0, 3.5, 21, 45 h ￿FBF post ischemia at 
Lag3.5
Törnqvist et al., 2007 Mean age 26 yrs (18-38) Exp. Diesel PM: 300 μg/m3; with exercise; 1 h Lag 24 h ￿FBF with vasodil. at 
lag24; -BP
Urch et al., 2005 Aged 18-50 yrs Exp. CAP~PM2.5: 147 μg/m3 (SD27) + O3; 2 h Lag0 ￿DBP
a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Inconsistent results were reported between population subgroups (e.g. 
normal and asthmatics);
Abbreviations: BAD: Brachial artery diameter; BC: Black carbon; BP: Blood pressure; C: Carbon; CAP: Concentrated Ambient Particles; COPD: chronic obstructive pulmonary disease; DBP: diastolic 
BP; Dur.: Duration of exposure; Epi.: Epidemiological; Exp.: Experimental; FBF: forearm blood flow measured by plethysmography; FMD: Flow mediated diameter; HT: Hypertensive; hrly: Hourly; 
MI: Myocardial infarction; O3: Ozone; OC organic carbon; PM: Particulate matter; SD: Standard deviation; SBP: systolic BP; UFP: Ultrafine particles; vasodil.: Vasodilators; -: No significant statistical 
association;
Table 3: Evidence of association between sub-daily exposure to PM and vasoconstrictiona (Continued)B
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Table 4: Evidence of association between sub-daily exposure to PM and coagulationa
Authors Subjects Design Exposure Levels Dur. Lags PL F t-PA Agc
Rückerl et al., 2007 Aged 51-76 yrs, with CVD Epi. Fixed site PM2.5 daily 
mean: 20 μg/m3 (SD15); 
UFP nb, PM10 also 
measured;
6 hb Lag0, 6, 12, 18 
h
￿ with UFP lag 0 and 18 h
Carlsten et al., 
2007
Mean age 25 yrs (21-43) Exp. Diesel PM: 100 and 200 
μg/m3
2 h Lag3, 6, 22 h -
Frampton et al., 
2004
Aged 18-40 yrs, 57% 
asthmatics
Exp. UFP: 10 or 25 μg/m3; with 
exercise;
2 h Lag0, 3.5, 15, 
21, 45 h
--
Ghio et al., 2000 Mean age 26 yrs (SD1) Exp. CAP~PM2.5: 23-311 μg/
m3; with exercise;
2 h Lag18 h - ￿
Gong et al., 2008 Aged 18-50 yrs, 45% 
asthmatics
Exp. CAP~UFP: 100 μg/m3 
(SD68); with exercise;
2 h Lag0, 4, 22 h - - -
Gong et al., 2004b Aged 54-85 yrs, 68% 
COPD
Exp. CAP~PM2.5 : 167 (SD27) 
μg/m3; with exercise;
2 h Lag0, 4, 22 h - -
Gong et al., 2003 Aged 18-45 yrs, 50% 
asthmatics
Exp. CAP~PM2.5 : 174 μg/m3 
(SD37); with exercise;
2 h Lag0, 4, 22 h - -
Lucking et al., 
2008
Aged 21-44 yrs Exp. Diesel PM: 350 μg/m3; 2 h Lag2 and 6 h -
Mills et al., 2008 Mean age 54 yrs (SD2), 
50% CVD
Exp. CAP~PM2.5 : 190 μg/m3 
(SD37); with exercise;
2 h Lag2, 6, 8 h ￿ at lag2 -
Mills et al., 2007b Mean age 60 yrs (SD1), 
with prior MI
Exp. Diesel PM: 300 μg/m3; 
with exercise;
1 h Lag6, 24 h ￿ at lag6
Mills et al., 2005 Aged 20-38 yrs Exp. Diesel PM: 300 μg/m3; 
with exercise;
1 h Lag2, 6, 24 h - ￿ at lag6B
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Routledge et al., 
2006
Aged 52-75 yrs, 50% CVD Exp. C UFP: 50 μg/m3; 1 h Lag4 and 24 h - -
Salvi et al. 1999 Aged 21-28 yrs Exp. Diesel PM: 300 μg/m3; 
with exercise;
1 h Lag 6 h ￿
Scharrer et al., 
2007
Mean age 29 yrs (SD8) Exp. Welding fume PM 50th: 
3500 μg/m3 (1000-
25300);
1 h Lag 5 h -
Törnqvist et al., 
2007
Mean age 26 yrs (18-38) Exp. Diesel PM: 300 μg/m3; 
with exercise;
1 h Lag 24 h - -
a Numbers are rounded to the nearest integer for simplification; b Exposure durations longer than 6 h also studied; c Except in Gong et al., 2008, t-PA antigen was measured following infusion 
of vasodilators;
Abbreviations: Ag: Antigen; C: Carbon; CAP: Concentrated Ambient Particles; CVD: Cardiovascular disease; COPD: chronic obstructive pulmonary disease; Dur.: Duration of exposure; Epi.: 
Epidemiological; Exp.: Experimental; F: Fibrinogen; MI: Myocardial infarction; PL: platelets; nb: number; PM: Particulate matter; SD: Standard deviation; t-PA Ag: tissue plasminogen activator 
antigen; UFP: Ultrafine particles; -: No significant statistical association;
Table 4: Evidence of association between sub-daily exposure to PM and coagulationa (Continued)Burgan et al. Environmental Health 2010, 9:26
http://www.ehjournal.net/content/9/1/26
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selected for analysis. While table 1 groups studies exam-
ining cardiovascular effects, Table 2, Table 3 and Table 4
group those addressing likely mechanisms by which sub-
daily PM exposure cause cardiovascular effects.
In total, 25 studies were epidemiological assessments;
most of these studies used a longitudinal design. Levels of
exposure to ambient particles in the epidemiological
studies were in the range of those observed today in
major American and European cities: The epidemiologi-
cal studies usually reported hourly or daily mean or
median PM2.5 levels (PM with median diameter < 2.5
μm) at fixed monitoring sites below 20 μg/m3. Exposure
levels in the experimental studies typically ranged
between 100 to 300 μg/m3 for one to two hours, which is
a high daily maximum value in epidemiological studies
performed in American and European cities. Particulate
exposure characteristics varied between studies and
included different particulate size fractions from fixed
sites and personal measurements for epidemiological
studies. Most experimental studies, on the other hand,
used either concentrated ambient particles (CAP) or die-
sel exhaust to expose volunteers. Furthermore, exposure
usually occurred with intermittent periods of exercise.
Studies included both young and elderly people, healthy
or with cardio-respiratory conditions and participants
under medication.
Cardiovascular effects of sub-daily exposures to fine 
particles
According to our assessment of studies presented in
Table 1, there is suggestive electrographic evidence that
sub-daily exposures to PM decrease the ST-segment
which most likely indicates ischemia of the myocardium:
of five studies (two experimental) that assessed ST-seg-
ment depression during exercise, three found increased
depression during and shortly after exposure. The experi-
mental study which did not observe any effects exposed
subjects aged < 50 years with no preexisting cardiovascu-
lar disease [9]. There are insufficient studies published to
date to assess the effects of lags and duration of exposure.
However, the experimental positive study by Mills et al.
[10] suggests that ischemia during exercise can occur
quickly after the start of exposure and that reversal of
ischemia may occur within less than an hour of continued
exposure.
As for fibrillation or arrhythmia, there is limited epide-
miological evidence of effects of sub-daily exposures to
PM in studies assessing patients with implantable defi-
brillators (n = 4) (Table 1): only one of four studies
reported a positive association with sub-daily levels of
PM. Studies performed by Gong et al, did not show asso-
ciation between sub-daily levels of PM and ectopic beats.
There is suggestive evidence that sub-daily exposures to
PM induce MI (Table 1): while there are a limited number
of studies addressing the issue, positive associations were
found in four out of five epidemiological studies per-
formed in older adults (mean age around 60 years); how-
ever there is insufficient information to assess if effects
occur shortly after exposure or if effects become more
pronounced as elapsed time since exposure increases.
Mechanisms whereby sub-daily exposures to fine particles 
may induce cardiovascular effects
The involvement of the autonomic nervous system has
been suggested as a potential mechanism whereby sub-
daily levels of PM may induce cardiovascular effects. In
our assessment of studies that measured heart rate vari-
ability (presented in Table 2), discrepancies in results
were noted between epidemiological (n = 11) and experi-
mental studies (n = 9): while most epidemiological stud-
ies showed a decrease in SDNN, experimental studies did
not report any associations. Contrary to epidemiological
studies, most experimental studies did not assess the
association in people with pre-existing cardiovascular
disease. Furthermore, most studies assessed the effects of
e x p o s u r e  a t  l a g 0  ( t h e  h o u r  b e f o r e  t h e  p h y s i o l o g i c a l
assessment). As such, variations in SDNN appear to
occur shortly after exposure; it is however impossible so
far to assess whether variations in SDNN occur only
shortly after exposure.
Regarding studies that assessed measurements of vaso-
constriction (n = 15), which were mainly experimental in
design, results were contradictory (Table 3): while blood
pressure (BP) was mainly invariable, suggestive evidence
of vasoconstriction was observed in studies where flow
mediated dilation (FMD) or forearm blood flow (FBF)
following vasodilator injection was measured. A positive
association was found for short [46] as well as longer lags
[48].
Finally, results of the 15 studies that assessed the effects
of sub-daily levels of PM on fibrinolytic activity and coag-
ulation were generally negative for change in the levels of
platelets and fibrinogen (Table 4). Some discrepancies
observed with levels of t-PA (a regulator of the degrada-
tion of intravascular fibrin) may be associated with the
exposure conditions, as suggested by experimental stud-
ies performed by the same authors [10,43,44,48]. Accord-
ing to these studies, it seems that diesel exposure would
influence fibrinolytic activity [10,44] but not concen-
trated ambient particles (CAP) [43]. Furthermore, this
association would be observed at lag 6 h [10,44] and not
at lag 24 h [48].
Discussion
This literature assessment was performed to answer three
main questions. First, do sub-daily exposures to PM
induce cardiovascular effects such as arrhythmia, isch-
emia and MI? Our assessment shows that there is sugges-Burgan et al. Environmental Health 2010, 9:26
http://www.ehjournal.net/content/9/1/26
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tive evidence that exposure to sub-daily levels of PM is
associated with MI and ischemic events (mainly in the
elderly and in individuals with prior cardiovascular dis-
eases). There is limited evidence of an association
between sub-daily levels of PM and arrhythmia or fibril-
lation; discrepancies observed may be due to method-
ological issues (see below). Our analysis was conducted
without considering the effect of variable PM size. Fur-
ther studies are needed to address the influence of PM
size and composition on the acute cardiovascular effects
of sub-daily exposure to PM as it may influence PM toxic-
ity. Furthermore, meta-analytic reviews for each outcome
should be performed to elucidate the magnitude of the
observed associations.
Secondly, this review also addresses mechanistic issues.
The delay with which cardiovascular effects appear fol-
lowing sub-daily exposure to PM was examined. Results
of our analysis show that there is limited evidence sug-
gesting that the cardiovascular effects of short duration
exposure to PM occur quickly following exposure. How-
ever there is one experiment by Mills et al. [10] that dem-
onstrates more pronounced myocardial ischemia during
exercise which occurs minutes after the start of exposure.
Further studies (experimental and epidemiological) are
thus needed to confirm that cardiovascular effects of sub-
daily exposure to PM may occur shortly, or with a short
lag period, after the end of exposure. Furthermore, the
reversal of ischemia observed in this study during expo-
sure [10] suggests that in studies assessing the cardiovas-
cular effects of PM, the timing of the health assessment
should be carefully selected. Indeed, health effects may be
missed due to the design of the study if the health assess-
ment is not made at the right time (i.e. at the beginning of
the exposure period).
Thirdly this review also addresses the physiological
processes underlying whereby short exposures to PM, as
opposed to longer averaging periods, may induce acute
cardiovascular effects such as ischemia and myocardial
infarction. According to the results of the studies
reviewed, there is suggestive evidence from epidemiolog-
ical studies that a plausible biological mechanism
whereby sub-daily PM levels may induce effects involves
the autonomic nervous system (as shown by studies on
SDNN) even though experimental studies did not indi-
cate this.
Discrepancies observed between epidemiological and
experimental studies that measured SDNN may be due to
differences in the number of repeated measures or to the
fact that younger subjects without preexisting cardiovas-
cular diseases were recruited in experimental studies.
Experimental studies need to assess effects in those with
pre-existing cardiovascular diseases to confirm associa-
tions observed in epidemiological studies between sub-
daily PM exposure and SDNN. Similar associations with
SDNN, as those reported here by epidemiological studies,
have been observed in occupational studies [58-60].
Occupational studies that we identified assessing the car-
diovascular effects of exposure to sub-daily PM (not
reviewed here) have mainly examined its association with
heart rate variability. The involvement of the autonomous
nervous system in the effects of sub-daily PM exposures
has also been suggested by studies on cardiac repolarisa-
tion (not reviewed here): an increase in QTC interval and
a decrease in T-wave amplitude with exposure to sub-
daily levels of PM have both been reported [55,57]. None-
theless, further studies are needed to clarify the patholog-
ical implications, the prognostic value of a short-term
decrease in heart rate variability (HRV) [61]. Further-
more, considerations are also needed to better under-
stand if a decrease in HRV is an indicator of an alteration
of the sympathetic tone. Further reviews should look at
other HRV time and frequency domain parameters than
SDNN.
Other physiological mechanisms, such as vasomotor
dysfunction, are also likely implicated in the acute cardio-
vascular effects of sub-daily exposure to PM but discrep-
ancies remain. For instance, associations between these
exposures and FBF were found for both short lags (<4 h)
and long lags (24 h) but no associations were found for
lags of 6 to 8 h [10,43]. While vasomotor dysfunction
does seem to be involved in the cardiac pathophysiology
of PM exposure, so far it is unlikely to underlie effects
such as ischemia, occurring during or immediately after
exposure (e.g. [10]) because of differences in lags between
exposure and onset of changes between the two. It is pos-
sible that vasomotor dysfunction may be involved in
effects occurring hours after exposure, perhaps following
the release of inflammatory mediators.
We performed a non-meta-analytical systematic litera-
ture review of studies that assessed a number of selected
cardiovascular effects and physiological measures. Our
literature review was framed by a theoretical model (pre-
sented in Figure 1) and, our quantitative assessment of
the evidence was limited to counting studies presenting
statistically significant associations. We recognize the
limitations of our approach to identify the presence of an
association which was based on statistical significance.
We also recognize the limitations of our evaluation of the
evidence of an effect as either 'suggestive' or 'limited',
which was based on the number of studies with signifi-
cant effects versus non-significant effects (i.e. suggestive
if more than half of the studies showed a statistically sig-
nificant association in the same direction). Our approach
to assess the evidence may be biased by the tendency to
publish positive results. Furthermore, issues of design
and power may have limited our ability to report real
associations. However, we consider our approach reason-
able as most epidemiological studies reviewed used a lon-Burgan et al. Environmental Health 2010, 9:26
http://www.ehjournal.net/content/9/1/26
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gitudinal design with numerous repeated measure and
thus, high power. Furthermore, while the present assess-
m e n t  d o e s  n o t  a l l o w  t h e  q u a n t i f i c a t i o n  o f  e f f e c t s ,  o u r
mechanistic framework does allow consideration of both
human experimental and epidemiological studies in
assessing the cardiovascular effects of exposure to sub-
daily PM exposures and identifies research gaps. Future
systematic reviews, mainly assessing the mechanistic
basis of sudden cardiovascular effects, should consider
including studies that assess physiological measures not
i n c l u d e d  i n  t h i s  a n a l y s i s ,  s u c h  a s  m a r k e r s  o f  s y s t e m i c
inflammation (e.g. C-reactive protein) and other indica-
tors of vasoconstriction or vasoconstriction agonists (e.g.
endothelin).
Based on our assessment of the literature, it appears
that further studies are needed to confirm that sub-daily
exposure to PM is associated with MI and ischemia as
well as to address the influence of the size and the com-
position of the PM. Additionally, the literature reviewed
does not provide any clear tendency as to the effects of
different concentrations of exposure: epidemiological
studies using linear models did not provide an exposure
effect threshold. More work is needed to characterise the
dose-response relationships. Studies should also address
whether the observed effects of sub-daily exposures to
PM are due to other concurrent air pollutants or to the
combined action of a number of contaminants. Indeed
while in the epidemiological studies we reviewed subjects
were exposed to mixtures of ambient air pollutants, in a
number of experimental studies showing associations
exposure was often to either diesel exhaust (itself a pol-
lutant mixture) or to CAP (concentrated ambient parti-
c l e s ) .  F u r t h e r m o r e ,  e x p o s u r e  a s s e s s m e n t  i n
environmental epidemiological studies, as opposed to the
highly controlled human experimental studies, can only
be  o b s e rva t i o n a l  a n d  a s  s u c h  i s  i m pe r f ec t  i n  a s s e s s i n g
true subject exposures especially in cases where central
pollution monitoring station data is used. Whether or not
this limitation is more of concern in epidemiological
studies with shorter sub-daily exposure assessment rather
t h a n  l o n g e r  a v e r a g e d  e x p o s u r e s  i s  n o t  c l e a r .  A n o t h e r
issue that deserves consideration is the influence of
smoking on the health response to PM. In most studies so
far, smokers were excluded or, the effect of smoking was
adjusted statistically (data not shown).
The physiological mechanisms underlying the associa-
tions between sub-daily exposure to PM and MI or isch-
emia need to be clarified. For instance, experimental
studies can be designed to better understand the time
course of such effects. It is difficult to sort out the time
course of effects with epidemiological studies as exposure
has usually not been instantaneous. The influence of pre-
existing cardiovascular diseases and medication use, on
the effects of sub-daily exposure to PM, also need to be
determined.
Finally, studies are needed to clarify if cardiovascular
effects of sub-daily exposure to PM are captured by daily
exposure. To date only daily levels of PM are subjected to
regulation whereas sub-daily exposures of PM are not
regulated. Information on this issue may be provided by
time-series studies, in assessing the association between
both daily mean PM levels and, hourly levels, with daily
deaths or emergency room visits for cardiovascular
effects. To our knowledge, very few studies (e.g. [56])
have assessed this so far, even with the limited effort that
it would require.
Conclusions
Future studies should clarify the points discussed above,
specifically to which PM size fraction, composition and
concurrent pollutants on sub-daily exposure, the cardio-
vascular effects are associated and by what mechanisms.
It is questionable whether obtaining sufficiently precise
information on these determinants is feasible with data
from central pollution monitoring stations as opposed to
personal monitors or an experimental study design.
Although studies are needed to strengthen the evidence,
our assessment of the literature on the effects of sub-daily
exposure to PM leads to the conclusion that exposures of
under 6 hours (including exposure as short as 30 to 60
minutes) may be associated with the occurrence of car-
diovascular effects such as ischemia and MI possibly in
the elderly and in individuals with prior cardiovascular
diseases. Given that exposure to sub-daily high levels of
P M (for a few hours) is fr equent, we r ec ommend t ha t
those with cardiovascular diseases avoid such situations.
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